Status:

COMPLETED

Stress Reduction Training for Emotion Regulation and Well-Being

Lead Sponsor:

Virginia Commonwealth University

Conditions:

Stress Reduction

Eligibility:

All Genders

21-55 years

Phase:

NA

Brief Summary

This study will examine whether stress reduction training - which a growing body of research indicates has manifold benefits for behavior regulation, emotion regulation, and other salutary outcomes of...

Detailed Description

This research study seeks to understand how stress reduction training influences neural responses (brain activation) and behavior related to stress, including emotions, desires, and reactions to adver...

Eligibility Criteria

Inclusion

  • English speaking (will not be advertised but screened)
  • Stable medication regiment for 8 weeks prior to enrollment if taking antidepressant or anxiolytic medications. (will not be advertised but screened)
  • Free of major, uncorrected sensory impairments and cognitive deficits
  • Free of a certain psychiatric disorders or history thereof; specifically, a new diagnosis of a (non-acute) medical or psychiatric condition within the last 3 months, report a hospitalization over the last 3 months, report current drug abuse (e.g., recreational drug use, alcohol intake in excess of 2 drinks per day).
  • Personal SmartPhone (Android or Apple operating systems).

Exclusion

  • non-English speaking
  • are unwilling or unable to complete study assessments or treatments
  • present fMRI safety risks (e.g., ferromagnetic implants, body weight \> 300 lbs)
  • report a new diagnosis of a (non-acute) medical or psychiatric condition within the last 3 months
  • report a hospitalization over the last 3 months
  • report current drug abuse (e.g., recreational drug use, smoke more than ½ pack per day, alcohol intake in excess of 2 drinks per day)
  • are prisoners or pregnant women
  • no personal SmartPhone (Android or Apple operating systems)

Key Trial Info

Start Date :

April 23 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 20 2019

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT03485807

Start Date

April 23 2018

End Date

December 20 2019

Last Update

February 19 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Virginia Commonwealth University

Richmond, Virginia, United States, 23298